Zyprexa and Haematocrit increased - a phase IV clinical study of FDA data

Summary:

Haematocrit increased is reported as a side effect among people who take Zyprexa (olanzapine), especially for people who are female, 30-39 old, have been taking the drug for 1 - 6 months also take Cogentin, and have Schizophrenia.

The phase IV clinical study analyzes which people have Haematocrit increased when taking Zyprexa. It is created by eHealthMe based on reports of 63,412 people who have side effects when taking Zyprexa from the FDA, and is updated regularly.

What is Zyprexa?

Zyprexa has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 64,724 Zyprexa users. Check the latest studies of Zyprexa.

What is Haematocrit increased?

Haematocrit increased is found to be associated with 406 drugs and 747 conditions by eHealthMe. Check the latest studies of Haematocrit increased.

On Jul, 12, 2026

63,412 people reported to have side effects when taking Zyprexa.
Among them, 33 people (0.05%) have Haematocrit increased.

Could Zyprexa cause Haematocrit increased?

Among these 33 people:

How long have people been on Zyprexa when they have Haematocrit increased? *

What is the gender of people who have Haematocrit increased when taking Zyprexa? *

female: 60.61 %
male: 39.39 %

What is the age of people who have Haematocrit increased when taking Zyprexa? *

What are other drugs people take besides Zyprexa? *

What are other side effects people have besides Haematocrit increased? *

Haemoglobin Increased: 18 people, 54.55%
High Blood Cholesterol: 15 people, 45.45%
Red Blood Cell Count Increased: 12 people, 36.36%
Diabetes: 11 people, 33.33%
Hyperglycemia (high blood sugar): 7 people, 21.21%
Type 2 Diabetes: 7 people, 21.21%
White Blood Cell Count Increased: 6 people, 18.18%
High Blood Pressure: 5 people, 15.15%
Vision Blurred: 5 people, 15.15%
Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 5 people, 15.15%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 6 people, 18.18%
Psychotic Disorder: 4 people, 12.12%
Pain: 2 people, 6.06%
Agitation (state of anxiety or nervous excitement): 2 people, 6.06%
Thinking Abnormal: 1 person, 3.03%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 1 person, 3.03%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 3.03%
Carpal Tunnel Syndrome (nerve compression at wrist results numbness weakness, pain , swelling): 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Zyprexa and have Haematocrit increased?

- Check whether Haematocrit increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zyprexa:

Zyprexa (64,724 reports)

Browse all side effects of Zyprexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haematocrit increased:

Haematocrit increased (406 drugs)

Browse all the conditions that are associated with Haematocrit increased:

Haematocrit increased (747 conditions)

Related publications that referenced our studies

Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on olanzapine (the active ingredients of Zyprexa) and Zyprexa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.